LSS303, characterized as a STING agonist, inhibits porcine reproductive and respiratory syndrome virus replication in vitro

Cliometrica · Springer Nature · 2026-11-12 · DOI: 10.1007/s11259-026-11628-z

Аннотация

Porcine reproductive and respiratory syndrome virus (PRRSV) remains a major constraint on global swine production, and no specific antiviral drug is currently available for clinical control. In this study, we evaluated the antiviral activity of a synthetic compound characterized as STING agonist (LSS303) against PRRSV infection in vitro. Cytotoxicity was assessed in Marc-145 cells and PAMs. Antiviral activity was evaluated by reverse-transcription quantitative PCR, western blotting, indirect immunofluorescence, and infectious virus titration. Pretreatment of Marc-145 cells with LSS303 reduced replication of the highly pathogenic PRRSV strain TA-12 in a concentration-dependent manner. At 5 μg/mL, LSS303 also reduced viral replication when applied before, during, or after infection. In PAMs, inhibitory activity was observed against the recombinant PRRSV strains Chah2022 (NADC30-like) and CHjs2022 (NADC34-like). These findings demonstrate cross-strain anti-PRRSV activity of LSS303 in vitro and support its further evaluation as a host-directed antiviral candidate. Whether effective exposure can be achieved in vivo remains to be determined.

Читать у издателя →

Похожие статьи